Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combretastatin A4 Phosphate”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Study completedNCT00653939
What this trial is testing

A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer

Who this might be right for
Tumors
Mateon Therapeutics 63
Early research (Phase 1)Study completedNCT00003768
What this trial is testing

Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT00077103
What this trial is testing

Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT01570790
What this trial is testing

Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Combretastatin A4 PhosphateAge-related Macular DegenerationAMD+2 more
Johns Hopkins University 8
Large-scale testing (Phase 3)Ended earlyNCT00507429
What this trial is testing

Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer

Who this might be right for
Anaplastic Thyroid Cancer
Mateon Therapeutics 80
Testing effectiveness (Phase 2)Study completedNCT00060242
What this trial is testing

Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT00395434
What this trial is testing

Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Mateon Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT01423149
What this trial is testing

Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Choroidal NeovascularizationMyopia, Degenerative
Mateon Therapeutics 23
Early research (Phase 1)Study completedNCT00003698
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Glasgow 35
Testing effectiveness (Phase 2)Study completedNCT00113438
What this trial is testing

Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors

Who this might be right for
CancerTumor
Mateon Therapeutics 13